How to Document Infectious Disease Consultations and Antimicrobial Stewardship Reports

A practical guide for infectious disease physicians and consulting clinicians on documenting ID consults, antimicrobial stewardship reviews, culture and sensitivity-guided treatment decisions, isolation protocols, and stewardship reporting. Includes note structure, fictional examples, and a pre-sign checklist.

An infectious disease consult carries a clinical responsibility that most other consultation types do not: the physician documenting it is often the last clinical safeguard before a patient receives weeks of a powerful antimicrobial, sometimes one with narrow safety margins. The note needs to show not just what the diagnosis is, but why this drug at this dose for this duration is the right call given the culture data, the patient's renal function, and the institutional resistance patterns.

This guide walks through the structure of an ID consult note, how to document pathogen identification and antimicrobial selection rationale, antimicrobial stewardship (AMS) reporting, and isolation or infection control documentation. It is written for ID-trained physicians, hospitalists requesting ID input, and clinical pharmacists participating in stewardship programs.

Why ID Consult Documentation Is Distinctive

A standard medicine consult note answers: "What is wrong, and what should we do?" An ID consult answers a more layered question: "What organism is likely responsible, how do we confirm it, what does the susceptibility profile mean in clinical context, and how do we treat this patient without accelerating resistance in the process?"

That clinical density has to be visible in the documentation. Payers auditing antibiotic courses look for documented medical necessity. Stewardship programs need legible records of antibiotic selection rationale to perform accurate antibiotic utilization (AU) reporting. Infection control teams need explicit isolation documentation to enforce contact or airborne precautions consistently across nursing shifts.

Under-documented ID consults are also a patient safety risk. If an ID physician recommends a 42-day course of IV vancomycin for prosthetic joint infection but does not document the rationale for duration, a covering provider may stop the course early, or extend it unnecessarily, based on incomplete information.

Structure of an ID Consult Note

Consultation Request and Reason for Referral

Document who is requesting the consult, from what service, and the clinical question being asked. This is not a formality. A consult request for "fever workup" requires a different note than one for "MRSA bacteremia source control guidance."

Example opening: "Consult requested by hospitalist service, Dr. Nadia Okonkwo, for evaluation and management recommendations for a 68-year-old male with hospital-acquired pneumonia unresponsive to standard-dose ceftriaxone after 72 hours, with worsening oxygenation. Specific question: review of sputum culture results and guidance on directed antimicrobial therapy."

Naming the specific question sharpens the note and makes it easier for the requesting team to identify the actionable recommendations quickly.

Patient History Relevant to Infectious Risk

ID consults require a targeted history that general medicine notes often skip or underweight. The relevant elements include:

Antimicrobial exposure history: List every antibiotic received in the past 90 days, dose, route, and duration. Recent antibiotic exposure is the single most predictive factor for drug-resistant organism risk.
Healthcare exposure: Prior hospitalizations within the past 12 months, dialysis, long-term care facility residence, or prior surgery. Each is an independent risk factor for multidrug-resistant organisms.
Geographic and travel history: Travel to regions with endemic organisms (e.g., coccidioidomycosis in the Southwest US, Plasmodium falciparum malaria in sub-Saharan Africa, New Delhi metallo-beta-lactamase (NDM)-producing Enterobacteriaceae in South Asia) must be documented explicitly.
Immune status: HIV status and CD4 count if known, immunosuppressive medications, solid organ or hematopoietic stem cell transplant history, asplenia, and any active malignancy or chemotherapy.
Allergy history with reaction type: A documented penicillin allergy with a vague "allergic reaction" history is not the same as anaphylaxis. Document the original reaction type, when it occurred, and whether skin testing or a graded challenge has been performed.

Physical Examination Findings Relevant to Source Identification

The ID-focused physical exam should document findings that narrow or confirm the infectious source. This is different from a complete ROS or head-to-toe exam.

Targeted findings to document:

Skin and soft tissue: Cellulitis borders (mark them), erythema tracking patterns, wound appearance with depth estimation, any fluctuance or induration
Vascular access sites: Appearance of all central and peripheral IV lines, including any erythema, tenderness, or discharge
Joint examination: Warmth, effusion, range of motion limitation, tenderness on palpation vs. passive motion
Pulmonary: Auscultation findings correlated with radiographic consolidation
Neurologic: Meningismus (neck stiffness, Kernig's and Brudzinski's signs) when CNS infection is in the differential

Documenting what you looked for and did NOT find is as important as documenting positive findings. "No meningismus, no focal neurologic deficits" supports your reasoning for deferring lumbar puncture.

Review of Diagnostic Data

This section is the analytical core of the ID consult note. It should not be a copy-paste of lab results but a clinical interpretation of those results.

Culture and Sensitivity Data

For each culture, document:

Specimen source and collection date: Blood cultures collected on Day 1 and Day 3, urine culture collected on Day 2, respiratory specimen collected on Day 3
Organism identified: Full species name using current taxonomy (e.g., Clostridioides difficile, not "C. diff" in the formal note; Klebsiella pneumoniae, not "Kleb")
Susceptibility profile: Minimum inhibitory concentrations (MICs) for key drugs, not just "susceptible/resistant." An MIC for vancomycin of 1 mcg/mL is clinically different from 2 mcg/mL even though both fall in the susceptible range.
Resistance mechanisms when identified: Extended-spectrum beta-lactamase (ESBL) production, carbapenemase production (KPC, OXA-48, NDM), methicillin-resistant Staphylococcus aureus (MRSA) on mecA gene detection, or vancomycin-resistant Enterococcus (VRE) via vanA/vanB genotype
Contamination vs. true pathogen assessment: Document your clinical reasoning for whether a positive culture represents true infection, colonization, or likely contamination. Two of four blood culture bottles growing coagulase-negative Staphylococcus in a patient with a central line requires different documentation than four of four bottles with MRSA.

Example: "Day 2 blood cultures: 4/4 bottles positive for MRSA. MIC for vancomycin: 1.0 mcg/mL. mecA gene detected. Assessment: true bacteremia, not contamination, given bilateral positivity, high colony count, and clinical picture consistent with bacteremic presentation. No ESBL or carbapenem resistance mechanisms identified."

Imaging and Procedural Data

When imaging is central to the infectious source identification, document your interpretation with ID-specific framing:

"CT chest with contrast reviewed: right lower lobe consolidation with air bronchograms, no cavitation, no pleural effusion, and no evidence of empyema. Findings consistent with bacterial pneumonia without complication. No mediastinal lymphadenopathy to suggest fungal infection or lymphoma."

Institutional Antibiogram Data

Where relevant, reference the institutional antibiogram to contextualize susceptibility patterns. If a patient's urine culture grows E. coli susceptible to ciprofloxacin, but your institution's antibiogram shows 42% ciprofloxacin resistance in community E. coli, that context belongs in the note because it explains why the susceptibility data should be confirmed and why empiric fluoroquinolone therapy was not started.

Assessment and Differential Diagnosis

State the most likely diagnosis, the supporting evidence, and the conditions you considered and are excluding. The ID differential is often narrower by the time a consult is requested, but documenting your reasoning protects both the patient and the physician.

For a patient with MRSA bacteremia, a complete assessment documents:

Source of bacteremia: Primary bloodstream infection vs. seeded from a remote focus (endocarditis, septic arthritis, vertebral osteomyelitis). Document whether echocardiography is needed, when it was or will be obtained, and the clinical features prompting its consideration (bacteremia duration greater than 72 hours, known valvular disease, IVDU history, persistent fever after line removal).
Complications assessment: Metastatic seeding sites based on history and exam.
Host factors affecting treatment: Renal function, hepatic function, drug interactions with current medications.

Antimicrobial Recommendations with Explicit Rationale

This is the section most frequently under-documented and most frequently scrutinized by stewardship programs and payers.

For each recommended antimicrobial, document:

Drug name: Full generic name, not abbreviation alone ("vancomycin" rather than just "vanco")

Dose and dose justification: "Vancomycin 1,500 mg IV q12h. Dose calculated based on total body weight of 82 kg and baseline CrCl of 68 mL/min per Cockcroft-Gault equation. Target AUC/MIC of 400-600 given MIC of 1.0 mcg/mL."

Route: IV vs. oral, and if oral is used for a condition typically treated IV (e.g., IV-to-oral (IVPO) step-down for uncomplicated urinary tract infection or skin and soft tissue infection), document the rationale for the step-down explicitly.

Duration: Not just "complete the course" but an explicit number of days with the clinical benchmark that will guide re-evaluation. "Plan for 14 days of IV vancomycin from the date of first negative blood culture. Duration will be reassessed at Day 7 with repeat echocardiogram results."

Monitoring plan: Document what will be checked and how often. "Vancomycin AUC-guided monitoring: draw 2-point PK sample after the third dose. Daily BMP to monitor renal function given AUC targets. Audiometry deferred unless tinnitus develops."

Drugs being stopped and why: If your recommendation includes stopping empiric antibiotics that the primary team started, document that explicitly with the reasoning. "Empiric piperacillin-tazobactam discontinued as blood cultures grew MRSA, for which pip-tazo has no meaningful activity. Risk of continued broad-spectrum coverage for a defined MRSA bacteremia outweighs benefit."

Fictional Example: ID Consult Recommendation Section

Patient context: Mr. Alejandro V., 54-year-old male with type 2 diabetes and stage 3 CKD, admitted for septic shock from a diabetic foot wound.

"Assessment: Right foot wound infection with associated bacteremia. Blood cultures Day 1 and Day 2: MRSA (2/4 bottles each day, MIC vancomycin 1.0 mcg/mL). Wound culture: MRSA, susceptible to vancomycin, daptomycin, linezolid; resistant to clindamycin and trimethoprim-sulfamethoxazole. Lower extremity X-ray: cortical irregularity of the first metatarsal consistent with early osteomyelitis. MRI foot ordered to better characterize bone involvement.

Recommendations:

Start vancomycin 750 mg IV q12h (dose reduced per CrCl of 28 mL/min). Target AUC/MIC 400-600. Pharmacy-guided AUC dosing requested.
Discontinue empiric cefazolin started on Day 1 (inadequate MRSA coverage).
Obtain transthoracic echocardiogram to evaluate for endocarditis given MRSA bacteremia persisting beyond 72 hours despite source control.
Surgical service has been contacted regarding wound debridement and bone biopsy to confirm osteomyelitis and guide definitive duration. If osteomyelitis confirmed: plan for 6 weeks of IV therapy from Day 0 of adequate surgical debridement.
Repeat blood cultures daily until two consecutive negative sets obtained."

This level of documentation shows the stewardship program exactly what was recommended, why, and what decision points will change the plan. It gives the primary team clear, actionable steps. And it gives a future provider the full clinical reasoning if the ID team rotates off.

Antimicrobial Stewardship Documentation

Antimicrobial stewardship programs (ASPs) operating under CMS Conditions of Participation (CoP) requirements need legible, structured documentation to fulfill reporting obligations and improve prescribing practices at the institutional level.

Prospective Audit and Feedback Notes

When stewardship performs a prospective audit of an existing antibiotic order without a formal consult, the documentation is typically shorter but must include:

Patient identifier, date, and service reviewed
Current antibiotic regimen reviewed (drug, dose, route, days on therapy)
Clinical indication as documented in the medical record
Stewardship recommendation: De-escalation, dose adjustment, duration clarification, IVPO conversion, or no change with rationale
Whether recommendation was accepted or declined by the primary team (document both outcomes; declined recommendations are important quality data)

Example AMS audit note: "Patient: male, 71 years, Day 4 of meropenem 1g IV q8h for urosepsis. Original indication: empiric coverage for urosepsis with concern for MDR organism given prior hospitalization. Urine and blood cultures finalized Day 2: E. coli, susceptible to ciprofloxacin (MIC 0.25 mcg/mL), resistant to ampicillin only. De-escalation recommended: discontinue meropenem, transition to ciprofloxacin 400 mg IV q12h for 5 additional days (total 7-day course for uncomplicated urosepsis). Recommendation discussed with primary team physician, Dr. Singh. Recommendation accepted. Order placed."

Days of Therapy and Length of Therapy Reporting

Days of therapy (DOT) is the standard stewardship metric tracked by CMS and reported to the National Healthcare Safety Network (NHSN). Document the start date, route, and stop date for every antibiotic in a format that allows DOT calculation without requiring chart review. A note that says "antibiotics started" without a date is useless for stewardship reporting.

For stewardship dashboards, DOT per 1,000 patient days is the key benchmark. Your consult documentation directly feeds this data. Structured, complete records reduce the manual extraction burden on pharmacy teams running stewardship programs.

Isolation and Infection Control Documentation

When an ID consult involves a communicable or multidrug-resistant organism, the documentation must explicitly address isolation requirements. Nursing staff enforce precautions based on physician documentation. An implicit assumption that someone has already ordered isolation is not adequate.

Contact Precautions

Document the specific indication for contact precautions by organism:

MRSA
VRE
Clostridioides difficile (requires soap-and-water hand hygiene, as alcohol hand gel is not sporicidal)
ESBL or carbapenem-resistant Enterobacteriaceae (CRE)
Scabies

Example: "Contact precautions initiated for MRSA bacteremia. Nursing staff notified. Private room assigned. Gown and gloves required for all patient contact. Household contacts counseled on hand hygiene. Cohorting not applicable given private room availability."

Droplet and Airborne Precautions

For respiratory pathogens, document the precaution tier and the specific organism or clinical syndrome:

Droplet precautions: Influenza, respiratory syncytial virus, pertussis, meningococcal disease (surgical mask required)
Airborne precautions: Pulmonary tuberculosis, Mycobacterium tuberculosis, measles, varicella, disseminated zoster (N95 respirator and negative pressure room required)

Example: "Patient placed in airborne precautions room 412 (negative pressure confirmed by nursing, pressure differential log reviewed). Airborne precautions initiated for rule-out pulmonary tuberculosis pending AFB smear and culture. Three induced sputum specimens requested on three consecutive mornings. SARS-CoV-2 PCR and Legionella urinary antigen also ordered. All personnel entering room to wear fit-tested N95 or higher respirator."

Contact Tracing and Notifiable Disease Reporting

When an organism or syndrome triggers public health reporting obligations, document:

The specific reportable condition and the applicable jurisdiction (state health department vs. CDC)
Date and method of report (phone, electronic, fax)
The name and title of the public health contact if a phone report was made
Any contact tracing initiated

Example: "Meningococcal meningitis confirmed by CSF culture, N. meningitidis serogroup B. Report filed with County Public Health Department on 04/27/2026 via mandatory electronic reporting system. Public health officer notified by phone at 14:30. Chemoprophylaxis for household and close contacts to be coordinated by public health. Hospital employee exposure assessed: ID attending and nursing staff who entered room without droplet precautions prior to isolation order notified. Occupational health consulted."

Failure to document public health notification leaves the institution exposed to regulatory liability, separate from the patient care consequences.

Common Documentation Mistakes in ID Consults

Copying culture results without interpreting them. A note that pastes the lab report and says "susceptibility profile as above" does not document your clinical reasoning. Which drug do you recommend and why?

Vague duration language. "Complete a full antibiotic course" is not a documented duration. State the number of days and the clinical event that anchors Day 1 (e.g., first negative blood culture, first day of source control surgery, day of confirmed diagnosis).

Failing to document drugs being stopped. If your recommendation is to narrow therapy, document what you are stopping and why. A prescriber who sees an active antibiotic order may not know the ID team intended to stop it.

Missing MIC values. Susceptibility category alone (susceptible, intermediate, resistant) is not sufficient when prescribing agents with concentration-dependent or AUC-dependent pharmacodynamics. Vancomycin and carbapenems in particular require MIC values in the note.

Isolation documentation left to nursing. The physician note should confirm what precaution tier is in place and why. Do not assume isolation is documented elsewhere.

Omitting allergy details. A penicillin allergy documented only as "PCN allergy" without reaction type perpetuates unnecessary avoidance of an entire antibiotic class. The ID note is an opportunity to clarify the allergy history and, where appropriate, recommend formal allergy evaluation.

No follow-up plan. ID consults should close with a clear statement of when ID will reassess, what data will guide the next decision point, and under what circumstances the primary team should call for urgent re-evaluation.

ID Consult Documentation Checklist

Use this checklist before co-signing any ID consult note.

Consult Framing

Requesting service and physician named
Specific clinical question documented
Date and time of consult request and ID evaluation recorded

History and Risk Factors

Antibiotic exposure in past 90 days documented
Healthcare exposure risk factors listed
Travel history obtained and documented (or explicitly noted as none)
Immune status documented
Allergy history with reaction type recorded

Diagnostic Data Interpretation

Each culture documented with organism, specimen source, collection date, and full susceptibility profile including MICs
Resistance mechanisms named when identified
Contamination vs. true pathogen assessment documented
Relevant imaging interpreted with ID-specific framing
Institutional antibiogram referenced when relevant

Antimicrobial Recommendations

Full generic drug name, dose, route documented
Dose justification based on weight, renal function, or PK/PD parameters
Treatment duration with specific number of days and Day 1 anchor
Monitoring plan with specific parameters and frequency
Drugs being stopped listed with clinical rationale
IVPO step-down criteria documented where applicable

Stewardship Documentation (if applicable)

DOT-eligible antibiotic start date, route, and stop date documented
Prospective audit recommendation and team response recorded
De-escalation or discontinuation rationale documented

Infection Control

Precaution tier documented (contact, droplet, airborne) with specific organism indication
Room assignment and environmental controls confirmed in note
Notifiable disease report documented with date, method, and contact name if phone report

Follow-Up

Next ID reassessment date or trigger documented
Decision points that will change current plan named explicitly
Criteria for urgent re-evaluation communicated to primary team

Many ID physicians and clinical pharmacists supporting stewardship programs use structured documentation templates to ensure that every note captures antimicrobial rationale, MIC values, and isolation documentation consistently across a high-volume consultation service. Tools like NotuDocs allow clinicians to build custom ID consult templates with required fields for organism identification, susceptibility data, and treatment duration anchoring, so nothing gets omitted under time pressure. The template-first approach also reduces the risk of documentation drift, where early consult notes are thorough and later follow-up notes become abbreviated summaries that leave key clinical reasoning unrecorded.